Jin Rong Jie·2025-08-05 06:50Group 1 - The core viewpoint of the article highlights the performance of Alibaba Health, which saw a stock price increase of 2.04% to 5.01 CNY per share, with a trading volume of 363 million CNY as of August 5 [1] - Alibaba Health is the flagship healthcare platform of Alibaba Group, focusing on self-operated pharmaceutical business, e-commerce platform business, and digital healthcare services [1] - The company leverages advanced digital technology and operational capabilities to provide accessible, efficient, and safe healthcare services to millions of families, creating an integrated online and offline pharmaceutical health service platform [1] Group 2 - As of the 2024 annual report, Alibaba Health reported total revenue of 30.598 billion CNY and a net profit of 1.432 billion CNY [2]